These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 28686393)

  • 1. [
    Dumoulin A
    Rev Med Suisse; 2016 Oct; 12(534):1694-1697. PubMed ID: 28686393
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The role of atypical pathogen: Mycoplasma pneumoniae and Chlamydia pneumoniae in the acute respiratory infection in childhood].
    Ouchi K
    Jpn J Antibiot; 2000 Jun; 53 Suppl B():13-21. PubMed ID: 12572086
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rapid defervescence after doxycycline treatment of macrolide-resistant Mycoplasma pneumoniae-associated community-acquired pneumonia in children.
    Lung DC; Yip EK; Lam DS; Que TL
    Pediatr Infect Dis J; 2013 Dec; 32(12):1396-9. PubMed ID: 23817339
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Macrolide-resistant Mycoplasma pneumoniae in adults with community-acquired pneumonia.
    Miyashita N; Oka M; ; Kawai Y; Yamaguchi T; Ouchi K
    Int J Antimicrob Agents; 2010 Oct; 36(4):384-5. PubMed ID: 20674283
    [No Abstract]   [Full Text] [Related]  

  • 5. Mycoplasma pneumoniae as a causative agent of community-acquired pneumonia in children: clinical features and laboratory diagnosis.
    Medjo B; Atanaskovic-Markovic M; Radic S; Nikolic D; Lukac M; Djukic S
    Ital J Pediatr; 2014 Dec; 40():104. PubMed ID: 25518734
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current Mycoplasma pneumoniae outbreak: Don't forget its role in Bickerstaff encephalitis.
    Lacampagne T; Guillotin V; Peuchant O; Belloir A; Sibon I; Bébéar C; Cazanave C
    Diagn Microbiol Infect Dis; 2024 Sep; 110(1):116418. PubMed ID: 38954862
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Survey of macrolide resistance in Mycoplasma pneumoniae in adult patients with community-acquired pneumonia in Beijing, China].
    Yin YD; Cao B; Wang H; Wang RT; Liu YM; Gao Y; Qu JX; Han GJ; Liu YN
    Zhonghua Jie He He Hu Xi Za Zhi; 2013 Dec; 36(12):954-8. PubMed ID: 24503430
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Survey of macrolide-resistant Mycoplasma pneumoniae in children with community-acquired pneumonia in Switzerland.
    Meyer Sauteur PM; Bleisch B; Voit A; Maurer FP; Relly C; Berger C; Nadal D; Bloemberg GV
    Swiss Med Wkly; 2014; 144():w14041. PubMed ID: 25254315
    [No Abstract]   [Full Text] [Related]  

  • 9. Diagnosis and treatment of Mycoplasma pneumoniae in children.
    Rogozinski LE; Alverson BK; Biondi EA
    Minerva Pediatr; 2017 Apr; 69(2):156-160. PubMed ID: 28178776
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Severe community-acquired pneumonia caused by macrolide-resistant Mycoplasma pneumoniae in a 6-year-old boy.
    Lung DC; Chan YH; Kwong L; Que TL
    Hong Kong Med J; 2011 Oct; 17(5):407-9. PubMed ID: 21979480
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Community outbreak of macrolide-resistant Mycoplasma pneumoniae in Yamagata, Japan in 2009.
    Suzuki Y; Itagaki T; Seto J; Kaneko A; Abiko C; Mizuta K; Matsuzaki Y
    Pediatr Infect Dis J; 2013 Mar; 32(3):237-40. PubMed ID: 23114374
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adult community-acquired pneumonia caused by macrolide resistant Mycoplasma pneumoniae.
    Isozumi R; Yoshimine H; Morozumi M; Ubukata K; Ariyoshi K
    Respirology; 2009 Nov; 14(8):1206-8. PubMed ID: 19732389
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antimicrobial therapy of macrolide-resistant Mycoplasma pneumoniae pneumonia in children.
    Lee H; Yun KW; Lee HJ; Choi EH
    Expert Rev Anti Infect Ther; 2018 Jan; 16(1):23-34. PubMed ID: 29212389
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Macrolide-resistant Mycoplasma pneumoniae: characteristics of isolates and clinical aspects of community-acquired pneumonia.
    Morozumi M; Takahashi T; Ubukata K
    J Infect Chemother; 2010 Apr; 16(2):78-86. PubMed ID: 20094751
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A study of community-acquired
    Yu HX; Zhao MM; Pu ZH; Ju YR; Liu Y
    Colomb Med (Cali); 2018 Jun; 49(2):160-163. PubMed ID: 30104808
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chlamydia pneumoniae and Mycoplasma pneumoniae.
    Blasi F; Tarsia P; Aliberti S; Cosentini R; Allegra L
    Semin Respir Crit Care Med; 2005 Dec; 26(6):617-24. PubMed ID: 16388430
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Emergence of Macrolide-Resistant Mycoplasma pneumoniae in Hong Kong Is Linked to Increasing Macrolide Resistance in Multilocus Variable-Number Tandem-Repeat Analysis Type 4-5-7-2.
    Ho PL; Law PY; Chan BW; Wong CW; To KK; Chiu SS; Cheng VC; Yam WC
    J Clin Microbiol; 2015 Nov; 53(11):3560-4. PubMed ID: 26338857
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Severe macrolide-resistant Mycoplasma pneumoniae pneumonia associated with macrolide failure.
    Cheong KN; Chiu SS; Chan BW; To KK; Chan EL; Ho PL
    J Microbiol Immunol Infect; 2016 Feb; 49(1):127-30. PubMed ID: 25556047
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mycoplasma pneumoniae community-acquired pneumonia (CAP) in the elderly: Diagnostic significance of acute thrombocytosis.
    Cunha BA; Pherez FM
    Heart Lung; 2009; 38(5):444-9. PubMed ID: 19755196
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The epidemiological characteristics and drug resistance of mycoplasma pneumoniae in patients with community-acquired pneumonia during 2011-2015 in 5 sentinel hospitals in Beijing].
    Shi WX; Wu SS; Gong C; Li AH; Huang F
    Zhonghua Yu Fang Yi Xue Za Zhi; 2017 Sep; 51(9):832-836. PubMed ID: 28881550
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.